FIELD: chemistry.
SUBSTANCE: invention refers to biotechnology, specifically to Noggin2 proteins and can be used in medicine. The signalling cascade activin is blocked by introducing Noggin2 in an organism, tissue or cell in amount effective to inhibit or decrease activin activity.
EFFECT: invention allows blocking effectively activity of protein activin.
2 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF BLOCKING SINGALLING PATHWAY ACTIVATED BY TGF-beta FACTOR DERRIERE IN ANIMAL CELLS | 2009 |
|
RU2407799C1 |
| METHOD OF BLOCKING SIGNAL PATH ACTIVATED BY TGF-beta FACTOR OF VgI IN ANIMAL CELLS | 2008 |
|
RU2391352C1 |
| METHOD FOR SIGNAL PATH BLOCKING ACTIVATED BY Wnt8 FACTORS IN ANIMAL CELLS BY MEANS OF NOGGIN FAMILY PROTEINS | 2011 |
|
RU2473561C1 |
| TRANSGENIC MOUSE USED FOR INVESTIGATION OF REPARATIVE REGENERATION OF SKIN WOUND | 2023 |
|
RU2823992C1 |
| METHOD OF CULTIVATION PLURIPOTENTIAL STEM CELLS | 2005 |
|
RU2375448C2 |
| METHOD OF STEM CELLS DIFFERENTIATION INTO MIOCARDIAL CELLS INDUCTION | 2004 |
|
RU2392315C2 |
| DIFFERENTIATION OF HUMAN EMBRYO STEM CELLS | 2008 |
|
RU2473684C2 |
| COFFEE PLANT WITH DECREASED ALPHA-D-GALACTOSIDASE ACTIVITY | 2002 |
|
RU2303349C2 |
| DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS | 2008 |
|
RU2465323C2 |
| METHODS OF DERIVING DIFFERENTIATED CELLS FROM STEM CELLS | 2009 |
|
RU2576003C2 |
